|
2022
|
Invention
|
Compositions and methods of seneca valley virus (svv) related cancer therapy. The present disclos... |
|
|
Invention
|
Engineered oncolytic herpesviruses. The present disclosure relates to recombinant oncolytic viral... |
|
|
Invention
|
Compounds, compositions, and methods of using thereof. The present disclosure includes, among oth... |
|
|
Invention
|
Encapsulated rna polynucleotides and methods of use. The present disclosure relates to recombinan... |
|
2021
|
Invention
|
Encapsulated rna replicons and methods of use. The disclosure relates to oncolytic virus derived ... |
|
|
Invention
|
Anti-dll3 antibodies and methods of use. The present disclosure provides anti-DLL3 binding constr... |
|
|
G/S
|
Pharmaceutical preparations and therapeutic preparations in the nature of medications and therape... |
|
2020
|
Invention
|
Dual viruses and dual oncolytic viruses and methods of treatment. The present disclosure provides... |
|
|
Invention
|
Oncolytic viral delivery of therapeutic polypeptides. Described herein are pseudotyped oncolytic ... |
|
2019
|
Invention
|
Encapsulated polynucleotides and methods of use. The present disclosure relates to polynucleotide... |
|
|
Invention
|
Oncolytic viral vectors and uses thereof. The present disclosure relates to recombinant viral vec... |
|
2018
|
Invention
|
Oncolytic viral delivery of therapeutic polypeptides. Described herein are oncolytic viruses comp... |
|
|
Invention
|
Oncolytic viral vectors and uses thereof. Oncolytic viral vectors that incorporate one or more of... |
|
2017
|
Invention
|
Pseudotyped oncolytic viral delivery of therapeutic polypeptides.
Described herein are pseudotyp... |
|
|
Invention
|
Pseudotyped oncolytic viral delivery of therapeutic polypeptides. Described herein are pseudotype... |
|
2015
|
G/S
|
Research and development of pharmaceutical and therapeutic preparations in the field of gene therapy |
